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Decreased alveolar oxygen induces lung inflammation
Abstract
Molecular mechanisms of the inflammatory reaction in hypoxia-induced lung injury are not well
defined. Therefore, effects of alveolar hypoxia were studied in rat lungs, exposing rats to 10% oxygen
over periods of 1, 2, 4, 6, and 8 h. An increase in the number of macrophages in bronchoalveolar lavage
fluid of hypoxic animals was shown between 1 and 8 h. Extravasation of albumin was enhanced after 1
h and remained increased throughout the study period. NF-kappaB-binding activity as well as mRNA
for TNF-alpha, macrophage inflammatory protein (MIP)-1beta, and monocyte chemoattractant protein
(MCP)-1 were increased within the first 2 h of exposure to hypoxia. Hypoxia-inducible factor
(HIF)-1alpha and intercellular adhesion molecule (ICAM)-1 mRNA were upregulated between 1 and 6
h. Elimination of alveolar macrophages by intratracheal application of liposome-encapsulated
clodronate led to a decreased expression of NF-kappaB binding activity, HIF-1alpha, TNF-alpha,
ICAM-1, and MIP-1beta. In summary, alveolar hypoxia induced macrophage recruitment, an increase in
albumin leakage, and enhanced expression of inflammatory mediators, which were mainly macrophage
dependent. Alveolar macrophages appear to have a prominent role in the inflammatory response in
hypoxia-induced lung injury and the related upregulation of inflammatory mediators.
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Madjdpour, C., U. R. Jewell, S. Kneller, U. Ziegler, R.
Schwendener, C. Booy, L. Kla¨usli, T. Pasch, R. C.
Schimmer, and B. Beck-Schimmer. Decreased alveolar
oxygen induces lung inflammation. Am J Physiol Lung Cell
Mol Physiol 284: L360–L367, 2003. First published October
11, 2002; 10.1152/ajplung.00158.2002.—Molecular mecha-
nisms of the inflammatory reaction in hypoxia-induced lung
injury are not well defined. Therefore, effects of alveolar
hypoxia were studied in rat lungs, exposing rats to 10%
oxygen over periods of 1, 2, 4, 6, and 8 h. An increase in the
number of macrophages in bronchoalveolar lavage fluid of
hypoxic animals was shown between 1 and 8 h. Extravasa-
tion of albumin was enhanced after 1 h and remained in-
creased throughout the study period. NF-B-binding activity
as well as mRNA for TNF-, macrophage inflammatory pro-
tein (MIP)-1, and monocyte chemoattractant protein
(MCP)-1 were increased within the first 2 h of exposure to
hypoxia. Hypoxia-inducible factor (HIF)-1 and intercellular
adhesion molecule (ICAM)-1 mRNA were upregulated be-
tween 1 and 6 h. Elimination of alveolar macrophages by
intratracheal application of liposome-encapsulated clod-
ronate led to a decreased expression of NF-B binding activ-
ity, HIF-1, TNF-, ICAM-1, and MIP-1. In summary, al-
veolar hypoxia induced macrophage recruitment, an increase
in albumin leakage, and enhanced expression of inflamma-
tory mediators, which were mainly macrophage dependent.
Alveolar macrophages appear to have a prominent role in the
inflammatory response in hypoxia-induced lung injury and
the related upregulation of inflammatory mediators.
hypoxia; inflammatory mediators; lung injury
ACUTE ALVEOLAR HYPOXIA is a condition that occurs in
various clinical situations. Causes are hypoventilation
induced, for example, by brain injury, intoxication, or
thoracic cage injury. Atelectasis results in a ventila-
tion/perfusion mismatch and alveolar hypoxia as well.
Pathophysiologically, acute exposure to hypoxia re-
sults in vasoconstriction of pulmonary arteries and a
redistribution of blood flow from the basal to the apical
portion of the lung (13). It is not well documented
whether, at the same time, acute hypoxia also induces
changes at the level of pulmonary inflammatory medi-
ators. Most of the in vivo studies performed to date
have concentrated on ischemia-reperfusion injury in
organs (15, 18). However, the direct effects of hypoxia
without reperfusion on tissue have not been well ex-
plored. In addition, studies performed in lungs have
focused on lesions after exposure to hypoxia over sev-
eral days (24, 32). The acute hypoxia-induced lung
injury has not been described in detail. One potential
reason might be that the lungs have not been regarded
as a main target organ of hypoxia. On the basis of
evidence from in vitro data, we assumed that short-
term hypoxia might lead to lung injury (3).
Lung inflammatory response is regulated by the co-
ordinated function of cytokines, chemokines, and ad-
hesion molecules. Cell adhesion molecules such as the
group of selectins, integrins, and the immunoglobulin
gene superfamily have been shown to play a key role in
the inflammatory response, mediating different steps
of leukocyte migration through the endothelium (11).
Cytokines are best known for their leukocyte chemoat-
tractant activity, whereas chemokines orchestrate the
complex cellular interactions and mediate different
steps of migration of leukocytes through the endothe-
lium (11). It has been shown that macrophage inflam-
matory protein-1 (MIP-1) plays a key role in the IgG
immune complex-induced lung injury, whereas mono-
cyte chemoattractant protein-1 (MCP-1) dominates the
regulation of IgA immune complex-induced lung injury
(5, 14). An important signal transduction element is
the transcriptional factor nuclear factor-B (NF-B).
Upon stimulation by viruses, cytokines, lipopolysac-
charides (LPS), and also hypoxia, NF-B translocates
to the nucleus. There it binds to specific promoters and
induces gene transcription of various cytokines, che-
mokines, and adhesion molecules (1). Another tran-
scriptional factor relevant to hypoxia is hypoxia-induc-
ible factor-1 (HIF-1), composed of the oxygen-sensitive
HIF-1 and HIF-1 subunits. Although the HIF-1
subunit is expressed constitutively, HIF-1 expression
in the lung is regulated by the inspired oxygen concen-
tration (35). Several target genes of HIF-1 have been
identified, including cyclooxygenase-1, interleukin-6,
and vascular endothelial growth factor (28).
Alveolar macrophages are situated at the air-tissue
interface in the alveoli and are therefore among the
first cells in contact with inhaled organisms or sub-
stances. They not only act as phagocytes but also se-
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crete biologically active products, thereby playing an
important role in regulating inflammatory reactions
(29). Intratracheal instillation of liposomes contain-
ing dichloromethylene diphosphonate induces alveolar
macrophage depletion (33). The liposome-encapsulated
diphosphonate is ingested by phagocytic cells only and
results in selective depletion of alveolar macrophages.
This intervention allows us to characterize in vivo
function and role of alveolar macrophages (6, 17).
The following studies were undertaken to evaluate
hypoxia-induced lung injury, including changes in in-
flammatory mediators, and to elucidate the in vivo role
of alveolar macrophages in this model. We hypothe-
sized that alveolar macrophages might be the main
source of cytokines and chemokines in hypoxia-induced
lung alteration.
MATERIALS AND METHODS
Animal model of hypoxia. Male Sprague-Dawley rats (250–
300 g) were anesthetized with Hypnorm (fentanyl-flua-
nisone, 0.25 ml/kg sc) and Domitor (medetomidine hydrochlo-
ridum, 0.25 ml/kg sc). Animals were placed in a hypoxic
chamber with decreasing oxygen tension from 21 to 10%
within 60 min. Oxygen was substituted with nitrogen by a
Digamix 2M 302/a-F pump (Woesthoff, Bochum, Germany).
The gas flow rate was 37 l/min in a closed Persplex chamber.
CO2 tension was maintained normal. Animals remained un-
der 10% oxygen for 1, 2, 4, 6, and 8 h, respectively. Rehydra-
tion was ensured by intraperitoneal application of saline. At
predefined time points, animals were euthanized. For bron-
choalveolar lavage, 10 ml of cold phosphate-buffered saline
(PBS) were gently instilled into the lungs, withdrawn, and
reinstilled four times and collected. All experimental proce-
dures (determination of extravascular albumin, analysis of
interstitial neutrophil accumulation, and evaluation of ex-
pression of transcriptional factors and mRNA of various
genes) were performed on the same lungs (different lobes) of
the respective experimental animal.
All animals were housed in individual isolator cages
within the Animal Care Facilities at the University of Zurich
until the day of experimentation. The experimental protocols
were approved by the animal care committees at the Univer-
sity of Zurich.
Alveolar macrophage depletion. Clodronate-liposomes
were prepared as previously described (23, 27). Briefly, lipo-
somes composed of 880 mg soy phosphatidylcholine, 132 mg
cholesterol, and 5 mg DL--tocopherol were prepared in a
clodronate solution (375 mg clodronate in 10 ml Ostac;
Boehringer, Mannheim, Germany) by freeze-thawing and
filter extrusion. Unencapsulated clodronate was removed
with an Amicon ultrafiltration cell, followed by size exclusion
chromatography on a Sephadex G25 column. For the in vivo
experiments, liposomes were diluted in sterile saline in a
total volume of 300 l. Each animal received a dose of 500 g
of liposome-encapsulated clodronate. Empty liposomes were
used as controls. Rats were anesthetized, and liposomes were
administered intratracheally. Hypoxia experiments were
started 72 h later.
Bronchoalveolar lavage fluid. Bronchoalveolar lavage fluid
(BALF) was centrifuged at 2,000 rpm. Supernatant was ali-
quoted and frozen at 20°C. Cell pellets from centrifuged
BALF were assessed for differential cell counts using cyto-
spins and Diff-Quick (Dade Behring, Duedingen, Switzer-
land). At the same time, cells were identified with neutrophil-
and macrophage-specific antibodies. Cells were blocked with
PBS-10% fetal bovine serum (FBS) and incubated overnight
at 4°C with primary antibody. Neutrophils were identified
with a monoclonal mouse anti-rat neutrophil antibody (20
g/ml), and macrophages with a monoclonal mouse anti-rat
macrophage antibody (5 g/ml) (both from PharMingen, San
Diego, CA). A secondary fluorescein isothiocyanate-(FITC)-
or Cy-3-labeled goat anti-mouse antibody was added for 45
min at 4°C, together with 4,6-diamidino-2-phenylindole (1:
500 diluted). The FITC-labeled antibody was diluted 1:50 in
PBS-1% bovine serum albumin, the Cy-3-labeled antibody
1:500. All washing steps were performed with PBS. Cells
were counted under an epifluorescence microscope.
Albumin extravasation. Extravasation of albumin was de-
termined by a direct albumin enzyme-linked immunosorbent
assay (ELISA) according to an earlier protocol (20). BALF
from injured lungs (8 ml) was analyzed with the ELISA. A
coating carbonate buffer (0.1 M carbonate, pH 9.5) was used
to dilute samples (1:1,000), and a standard curve was created
with recombinant rat albumin (RDI, Flanders, NJ). A 96-well
plate was coated with 100 l/well and incubated overnight at
4°C. All washing steps (5 times with 200 l/well) were per-
formed with PBS-0.05% Tween 20. To block nonspecific bind-
ing, we added 3% dry milk in PBS for 1 h at 4°C. A first
polyclonal rabbit anti-rat albumin antibody (RDI) was di-
luted in PBS-3% dry milk to a concentration of 10 g/ml and
incubated for 1 h at 4°C (100 l/well). A secondary horserad-
ish peroxidase-labeled goat anti-rabbit antibody (Sigma,
Buchs, Switzerland) was added to the wells for 1 h at 4°C
(100 l/well). To develop color reaction, we added o-phenyl-
enediamine dihydrochloride (Sigma) to the wells (200 l/
well). The reaction was stopped with 3 M H2SO4, and optical
density was determined at 492 nm (ELISA reader; Biocon-
cept, Allschwil, Switzerland). To verify the results, BALF
was also run on a SDS-PAGE gel and analyzed with Coomas-
sie staining.
Tissue myeloperoxidase content. Lungs were homogenized
in a buffer containing 50 mM potassium phosphate, 0.5%
hexadecyltrimethylammonium bromide, and 5 mM ethyl-
enediaminetetraacetic acid (EDTA), sonicated, and centri-
fuged as described earlier (10). Supernatant (50 l) was
added to 1,450 l of assay buffer, consisting of 100 mM
potassium phosphate, o-dianisidine hydrochloride, and 30%
H2O2. The reaction was assayed every 10 s at 420 nm (ELISA
reader). The results are shown as the slope of change in
optical density over 360 s. Control values were defined as 1,
whereas results from hypoxic lungs were normalized to the
value of 1.
Nuclear extracts and electrophoretic mobility shift assay.
Nuclear extracts were prepared according to Schreiber et al.
(26). Briefly, lungs were homogenized in ice-cold buffer A [10
mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM
ethylene glycol-bis(-aminoethyl ether)-N,N,N,N-tetraace-
tic acid (EGTA), 1 mM dithiothreitol (DTT), and 0.5 mM
phenylmethylsulfonyl fluoride (PMSF)]. Lysis was induced
with 0.25% Nonidet P-40. After centrifugation, nuclear pel-
lets were resuspended in ice-cold buffer B (20 mM HEPES pH
7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycero1,
mM DTT, and 1 mM PMSF) and rocked at 4°C for 1 h. The
extracts were centrifuged, and supernatants were frozen at
70°C. The protein concentration of the extracts was deter-
mined using the Bradford method (Bio-Rad, Hercules, CA).
Nuclear extracts were then analyzed with electrophoretic
mobility shift assays (EMSA) for the DNA binding activity of
NF-B using a double-stranded oligonucleotide probe with
the sequence 5-AGT TGA GGG GAC TTT CCC AGG C-3
(consensus site underlined) (Promega, Madison, WI). End
labeling was accomplished by treatment with T4 kinase in
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the presence of [-32P]ATP. Extracts were then incubated for
50 min at room temperature with labeled NF-B oligonucle-
otide in binding buffer in the presence or absence of unla-
beled competitor oligonucleotide. DNA-protein complexes
were resolved in nondenaturing 5% acrylamide gels in 0.03%
Tris-boric acid plus EDTA buffer at 270 V. Gels were dried
and exposed to X-OMAT KODAK film (Sigma) and developed
after 6 h.
Protein analysis (Western blot) for intercellular adhesion
molecule-1. A crude membrane fraction from the lungs was
obtained following a protocol described earlier (34). Whole
lung protein (20 g) was electrophoresed in a 12.5% SDS-
polyacrylamide gel. After separation, the proteins were
transblotted to a nitrocellulose membrane for 1 h at 150 V
(Bio-Rad). Equal loading of proteins was confirmed by Pon-
ceau S staining. The blot was washed in PBS and blocked
with PBS-5% low fat milk-0.1% Tween 20 for 1 h at room
temperature, followed by an overnight incubation with mono-
clonal mouse anti-rat intercellular adhesion molecule
(ICAM)-1 antibody (Serotec, Oxford, England) in blocking
buffer. All washing steps were performed three times with
PBS-0.1% Tween 20. A secondary horseradish peroxidase-
labeled anti-mouse IgG (1:5,000) in blocking buffer was
added for 30 min at room temperature. Signals were detected
by enhanced chemiluminescence.
RNA analysis. Total RNA from lungs was extracted as
previously described (3) and analyzed by reverse transcrip-
tase polymerase chain reaction (RT-PCR) using a kit (Perkin-
Elmer, Branchburg, NJ). Random hexanucleotide primers
and murine leukemia virus RT were used for cDNA synthe-
sis. Reverse transcription was performed with 0.8 g of RNA
at 20°C for 5 min, 42°C for 30 min, and 99°C for 5 min.
Specific primers located on separate exons were designed to
assess gene expression of TNF-, ICAM-1, MIP-1, MCP-1,
and HIF-1, (Table 1). RT-PCR products were resolved on
1.5% agarose gels and stained with ethidium bromide. Gels
were then photographed under ultraviolet light. PCR was
also performed with 18S primers to ensure equal loading.
In vitro assay with alveolar macrophages. Alveolar macro-
phages were collected as described previously (3). Cells (1 	
107 cells/plate) were cultured for 1 h in DMEM with glu-
tamax (Life Technologies, Basel, Switzerland) supplemented
with 10% FBS. After becoming adherent, they were exposed
to 5% oxygen for 5 h, while control cells stayed at 21%. A cell
incubator (Bioblock, Ittigen, Switzerland) adjustable to dif-
ferent oxygen concentrations by insufflation of nitrogen was
used as a hypoxic cell chamber (3). Supernatant was collected
and analyzed with a TNF- and MCP-1 enzyme-linked
ELISA purchased from PharMingen.
Statistical analysis. All experiments were performed at
least five times. Albumin ELISA contained four to six repli-
cates with five different animals. Each data point in the
graphs represents mean 
 SE. Analysis of variance
(ANOVA) with post-ANOVA comparison was performed to
assess statistical significance of differences.
RESULTS
Depletion of macrophages. Before experiments with
clodronate-liposomes were started, different depletion
conditions were evaluated. Depletion time was varied
between 24 and 72 h, with the most effective depletion
observed after 72 h. Several concentrations of clod-
ronate were used (100, 500, 1,000, and 1,500 g).
Optimal depletion was seen at a dose of 500 g,
whereas with increased concentrations of clodronate,
enhanced neutrophil accumulation was observed. This
phenomenon of neutrophil recruitment induced by
clodronate is a known observation (6). Depletion was
verified with macrophage staining in BALF and tissue
(data not shown).
BALF cells. As seen in Fig. 1A, the cell number
increased after 1 h (170% increase, P  0.05), being
upregulated over a period of 8 h (300% at 2 h, 240% at
4 h, 350% at 6 h, and 150% at 8 h; P  0.05 for all
values compared with control). This increase appeared
to be almost exclusively due to macrophages as deter-
mined by fluorescence staining. Neutrophils were seen
after 4 and 6 h, but the contribution to total cell count
was only 13% at 4 h and 8% at 6 h (P  0.05). After
macrophage depletion, total cell number did not
change quantitatively under hypoxia, but the total
ratio of cell types changed (Fig. 1B). The increase of the
number of neutrophils compared with nondepleted an-
imals after 2 or 4 h of hypoxia was due to clodronate, as
verified in normoxic control liposome and clodronate
animals (6).
Hypoxia-induced neutrophil activation. Tissue my-
eloperoxidase (MPO) increased by 230% at 1 h (P 
0.01) and by 35–80% between 2 and 8 h (P 0.05) (Fig.
2). Intervention with intratracheally applied clod-
ronate-liposomes did not have an effect on MPO values
at 2 and 4 h of hypoxia (data not shown).
Extravasation. Exposure to 10% oxygen caused a
100% increase in albumin extravasation as early as 1
Table 1. Optimized conditions for RT-PCR for whole lung mRNA
Gene Primers
Thermocycle Conditions
No. of Cycles Annealing Temperature, °C
TNF- 5-ACT GAA CTT CGG GGT GAT TG-3 27 57
5-GTG GGT GAG GAG CAG GTA GT-3
ICAM-1 5-AGG TAT CCA TCC ATC CCA CA-3 24 58
5-CTT CAG AGG CAG GAA ACA GG-3
MIP-1 5-CGT GTC TGC CTT CTC TCT CC-3 32 58
5-CAC AGA TTT GCC TGC CTT TT-3
MCP-1 5-TAT GCA GGT CTC TGT CAC GC-3 32 58
5-TTC CTT ATT GGG GTC AGC AC-3
HIF-1 5-TCA AGT CAG CAA CGT GGA AGG-3 26 58
5-TAT CGA GGC TGT GTC GAC TG-3
ICAM, intercellular adhesion molecule; MIP, macrophage inflammatory protein; MCP, monocyte chemoattractant protein; HIF, hypoxia-
inducible factor.
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and 2 h (P  0.05), as assessed by the transpulmonary
flux of albumin (Fig. 3A). After 4 h of hypoxia, albumin
concentration even increased by 200% (P  0.005). A
similar result was seen in the Coomassie staining of a
SDS-PAGE gel performed with BALF (Fig. 3B). To
evaluate the influence of alveolar macrophages on vas-
cular permeability, we measured albumin in BALF of
normoxic and hypoxic control liposome and clodronate
animals. However, there was no difference in vascular
permeability between hypoxic animals with or without
macrophages (data not shown).
Determination of NF-B. NF-B as an essential acti-
vator of many inflammatory mediators was determined
by EMSA. As seen in Fig. 4A, a peak in NF-B DNA-
binding activity was observed at 1 and 2 h. NF-B in
LPS-injured lungs was assessed as positive control (4).
Increased NF-B binding was completely inhibited by
preincubation of nuclear extracts with an excess of unla-
beled consensus oligonucleotide competitor. Clodronate-
liposome pretreated animals showed less whole lung
NF-B binding activity compared with control liposome
animals after 2 h exposure to hypoxia (Fig. 4B).
Determination of mRNA for HIF-1. RT-PCR of
whole lung HIF-1 showed a baseline expression of
HIF-1 in control lungs. This is also known from
mouse brain and skeletal muscle with HIF-1 expres-
sion in normoxic animals (31). HIF-1 expression was
Fig. 1. A: cell analysis in bronchoalveolar lavage fluid (BALF). Rats
were exposed to normoxia or hypoxia for 1, 2, 4, 6, and 8 h. The black
part of the bars represents macrophages, whereas the gray part
reflects neutrophils. Statistically significant difference from animals
exposed to hypoxia compared with control animals: *P  0.05.
Values are means 
 SE from 5 animals. B: the same analysis was
performed in control liposome (co lip)- and clodronate-liposome ani-
mals with normoxia and hypoxia for the time points of 2 and 4 h.
Statistically significant difference from clodronate-treated animal
compared with control liposome animals: *P  0.01. Values are
means 
 SE from 5 animals. n.s., Not significant.
Fig. 2. Hypoxia-induced neutrophil activation in the lung. Lungs of
normoxic or hypoxic animals were homogenized, and myeloperoxi-
dase (MPO) was analyzed. Values are means 
 SE from 5 animals.
Statistically significant difference from animals exposed to hypoxia
compared with control animals: *P  0.05, **P  0.01.
Fig. 3. Albumin extravasation. A: normoxic or hypoxic lungs were
lavaged, and albumin was analyzed in BALF by ELISA. Values are
means 
 SE from 5 animals. Statistically significant difference from
animals exposed to hypoxia compared with control animals: *P 
0.05, **P  0.005. B: samples were also electrophoresed on a SDS-
PAGE gel and stained with Coomassie blue. SM, size marker.
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increased after 1 h of hypoxia compared with control
animals and remained upregulated (Fig. 5A). Interest-
ingly, macrophage depletion led to a downregulation
(Fig. 5B).
Upregulation of rat mRNA for TNF-, ICAM-1, MIP-
1, and MCP-1 in whole lung. To confirm equal load-
ing, we chose 18S as an internal standard. mRNA for
TNF- increased after 1 and 2 h, leveling off within 4 h.
ICAM-1 mRNA exhibited a significant increase after
1 h of hypoxia, which persisted up to 8 h after injury.
MIP-1 mRNA and mRNA for MCP-1 both peaked
between 1 and 2 h (Fig. 6A). Macrophage depletion lead
to a clear downregulation of mRNA for TNF-,
ICAM-1, and MIP-1 compared with control liposome
animals (Fig. 6B), whereas mRNA for MCP-1 was not
changed (data not shown).
To assess a potential correlation of the response of
mRNA for ICAM-1 to hypoxia with ICAM-1 protein
expression, we determined whole lung ICAM-1. As
shown in Western blot analysis, ICAM-1 protein in-
creased after 2 h and remained upregulated over 8 h
(Fig. 6C). These results demonstrate that enhanced
expression of ICAM-1 protein occurs at a transcrip-
tional and translational level.
TNF- and MCP-1 production of alveolar macro-
phages under hypoxic conditions. To analyze the in
vitro expression pattern of TNF- and MCP-1 of alve-
olar macrophages, we exposed cells to hypoxia for 5 h.
TNF- and MCP-1 proteins were measured in the
supernatant. As seen in Fig. 7A TNF- was increased
from 54 up to 89 pg/ml (68% increase, P  0.01),
whereas MCP-1 production during hypoxia was en-
hanced by 50% (P  0.01) (Fig. 7B).
DISCUSSION
These studies demonstrate for the first time that
acute exposure of rats to moderate hypoxia results in a
mild lung injury. The injury was characterized by the
accumulation of macrophages, a modest neutrophil in-
flux, and an increased accumulation of extravascular
albumin. On the level of inflammatory mediators,
DNA-binding activity of NF-B and expression of
mRNA for HIF-1, TNF-, ICAM-1, MIP-1, and
MCP-1 were increased.
Fig. 5. Determination of hypoxia-inducible factor (HIF)-1 mRNA.
Whole lung RNA was extracted, and RT-PCR was performed accord-
ing to the primers and annealing thermocycle conditions shown in
Table 1. Equal loading was shown with 18S bands. A: analysis of
mRNA for HIF-1 in rat lung after 1, 2, 4, and 6 h of exposure to
hypoxia. B: analysis of HIF-1 in rat lung in control liposome (co lip)
and clodronate-liposome animals after 2-h exposure to hypoxia. The
blots represent 1 of 5 experiments.
Fig. 4. Determination of NF-B DNA-binding activity. Nuclear ele-
ments were extracted from whole lungs previously exposed to nor-
moxia or hypoxia for 1, 2, 4, and 6 h (A). As a positive control, nuclear
extract from a 6-h LPS lung was taken. EMSA for NF-B was
performed. The same analysis is shown in animals treated with
control (co) liposomes and clodronate-liposome after 2 h exposure to
normoxia and hypoxia (B). Specificity for NF-B was shown by using
competitive unlabeled NF-B oligonucleotides. The blots represent 1
of 5 experiments.
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Compared with other acute inflammatory processes
in the lung such as LPS-induced or immune complex-
induced lung injury, only a slight increase of mRNA
and protein for ICAM-1 under hypoxia was observed (4,
19, 25). Whole lung mRNA for ICAM-1 was increased
by 300% in the LPS lung injury and by 250% in the IgG
immune complex-induced lung injury. In the hypoxia-
induced lesion, however, only a 77% increase of mRNA
for ICAM-1 was measured. Our previous in vitro stud-
ies support these data: alveolar epithelial cells (AEC)
under LPS stimulation showed a 600% increase of
mRNA for ICAM-1, whereas hypoxia led to a 100%
upregulation (3). One reason for the observed differ-
ences could be the severity of the injury, which is high
in the IgG- and LPS-induced inflammation models
with capillary leakage and a recruitment of neutro-
phils. The hypoxia-induced injury, however, results in
a mild lesion. Another explanation could be a different
functional role of ICAM-1 in the hypoxia-induced lung
injury. O’Brien et al. (21) recently showed that ICAM-1
on AEC played an important role in host defense
against Klebsiella pneumoniae. A protective function of
the upregulated adhesion molecule ICAM-1 could also
play a role in the hypoxic lesion. Furthermore, it could
be hypothesized that the inflammatory changes caused
by hypoxia represent a priming condition and gain in
severity in conjunction with an ensuing superimposed
injury. It could be shown in a cell model with alveolar
macrophages that LPS stimulation under hypoxia in-
creased injury compared with LPS stimulation alone
(16). Similar results were seen in a sepsis model of lung
injury. Under sublethal conditions, there was no evi-
dence of an inflammatory response in lungs of animals
with cecal ligation/puncture-induced sepsis alone.
However, after a direct intrapulmonary insult, en-
hanced lung injury in septic animals was observed (7).
The fact that vascular leakage is increased by
chronic hypoxia is not new. Stelzner et al. (30) showed
in vivo increased pulmonary extravasation of albumin
in rat lungs after 48 h of exposure to hypobaric hyp-
oxia. However, short-term exposure to hypoxia (1, 3, 6,
and 13 h) did not cause significant increases in extrav-
asation. These findings are not in accordance with our
results. Differences between the experimental systems
may partly explain this, since we were exclusively
investigating under decreased oxygen concentrations.
Stelzner et al., however, applied hypobaric hypoxia.
Although we determined extravascular albumin, our
results, however, do not explain the origin of the albu-
min (exudate, transudate). Theoretically, the intersti-
tial accumulation of albumin might be due to an en-
hanced inflammation-induced vascular permeability,
Fig. 6. Determination of whole lung
mRNA of TNF-1, intercellular adhe-
sion molecule (ICAM)-1, macrophage
inflammatory protein (MIP)-1, and
monocyte chemoattractant protein
(MCP-1) (A and B) and ICAM-1 protein
(C). Whole lung RNA was extracted,
and RT-PCR was performed. Equal
loading was shown with 18S bands. A:
analysis of mediators in rat lung after
1, 2, 4, 6, and 8 h of exposure to hyp-
oxia. B: analysis of mediators in rat
lung in control liposome (co lip) and
clodronate-liposome animals after 2 h
of exposure to hypoxia. C: whole lung
ICAM-1 protein in rat lungs exposed to
normoxia or hypoxia. Membrane pro-
teins were extracted, electrophoresed
on a SDS-polyacrylamide gel, and
transblotted to a nitrocellulose mem-
brane. ICAM-1 was determined after 1,
2, 4, 6, and 8 h of exposure to hypoxia.
The blots represent 1 of 5 experiments.
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but also to hypoxic vasoconstriction with transudation.
This question was previously analyzed with the help of
a special experimental setup (30). Stelzner et al. mea-
sured hemodynamic changes in the pulmonary vascu-
lar system as well as protein leakage in hypoxic rat
lungs. Although mean pulmonary pressures in hypoxic
animals were increased compared with pressure in
normoxic animals, no significant differences in protein
leakage index were seen in the two different groups,
assuming that hypoxic vasoconstriction is not respon-
sible for increased extravasation of albumin.
An interesting finding in our studies was the tran-
sient increase of mainly macrophages in BALF under
hypoxia. Compared with other models such as LPS- or
IgG-induced lung injury, neutrophil recruitment was
minimal. To evaluate whether these alveolar macro-
phages were the main source of mRNA of inflammatory
mediators in the case of hypoxia-induced lung injury,
we performed macrophage depletion. Theoretically,
other potential sources such as interstitial macro-
phages or nonmacrophage cell types might be respon-
sible for the production of mRNA of inflammatory me-
diators. Macrophage depletion, however, showed that
mRNA of the mediators were produced in alveolar
macrophages or at least induced by them. Hypoxia-
induced NF-B activation in whole lung tissue seems
to be macrophage dependent as well. This implies that
products of activated alveolar macrophages are re-
quired to stimulate nuclear translocation of NF-B,
which has been shown in the IgG model (17). The same
hypothesis can also be applied to enhanced whole lung
HIF-1, which is also attenuated by macrophage de-
pletion. Again, activation of HIF-1 might be triggered
by alveolar macrophages or even produced by macro-
phages. The fact that mRNA of inflammatory media-
tors is not completely abolished suggests the presence
of other sources for inflammatory mediators such as
interstitial macrophages, AEC, or endothelial cells. It
is well known that AEC are able to endocytose lipo-
somes (12). In view of the less than perfectly complete
macrophage depletion, a small residual fraction of al-
veolar macrophages could be another source of inflam-
matory mediators. Uneven distribution of the intratra-
cheal liposomes cannot be fully excluded in this
context. An interesting finding was the observation
that macrophage depletion did not affect MCP-1 ex-
pression compared with other inflammatory mediators.
Macrophages thus do not appear to be a main source of
MCP-1. Epithelial cells might be a more important
production site for MCP-1 as has been previously
shown in the kidney in tubular epithelial cells (2).
A very important aspect of the data in this model is
not only the inflammatory component, but also physi-
ological mechanisms. Alveolar hypoxia might increase
ventilation and therefore cause a mechanical disten-
sion of lung tissue. Few publications examine the im-
pact of hyperpnea on inflammatory mechanisms. Most
of these studies, however, were performed with dry air,
and experiments evaluated the effect of repetitive hy-
perpnea (8, 9, 22). Their results do not correlate with
our experiments. A potential impact of hyperpnea in
our model cannot be fully excluded.
MPO data provided valuable information. It could be
shown that hypoxia induced a slight interstitial accu-
mulation of neutrophils at an early time point of in-
flammation. Compared with other models of lung in-
flammation such as LPS-induced lung injury, however,
the magnitude of neutrophil infiltration was small.
These results support our interpretation that neutro-
phils are not the main effector cells in this model.
To further demonstrate the importance of alveolar
macrophages in the hypoxia-induced inflammation, we
studied the in vitro expression pattern of TNF- of alve-
olar macrophages. Interestingly, the increase of TNF-
production was not impressive compared with the in vivo
data. Therefore, we assume that not only the direct input
of alveolar macrophages is central in the hypoxic inflam-
matory reaction but also the indirect influence of these
cells on other cell types in the lung. Similar results were
also seen in IgG lung injury model (17).
In conclusion, this study demonstrates that acute
hypoxia results in inflammatory changes in the lung
representing a mild lung injury, whereby alveolar mac-
Fig. 7. Determination of TNF- and MCP-1 protein produced by
alveolar macrophages in vitro. TNF- (A) and MCP-1 (B) were
measured by ELISA in the supernatant of hypoxia-exposed alveolar
macrophages (5% oxygen, 5 h) and in control supernatants (21%
oxygen, 5 h). Values are means 
 SE of 5 different experimental sets
with duplicates.
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rophages are the main effector cells during this inflam-
matory response. The precise interaction of effector
cells with target cells in this model of acute hypoxia
will be further investigated.
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